Published on
03:12 GMT
Clinical trial for Longevity drug meets goal of enrolling 1000 dogs
The STAY study, a clinical trial investigating the developmental longevity drug LOY-002, has reached its goal of enrolling 1000 canine patients at 70 veterinary clinics across the US. According to Loyal, the biotechnology company developing LOY-002, this 4 …
Source:
dvm360
-
Pending
